MANAGEMENT OF ACUTE IMMUNOTHERAPY TOXICITY IN ONCOLOGY - Bentouati, Abdelkader
72,99 €
inkl. MwSt.
Versandkostenfrei*
Versandfertig in 6-10 Tagen
payback
36 °P sammeln
  • Broschiertes Buch

Immunotherapies have transformed the landscape of cancer treatment, but their power comes with specific toxic challenges. This book has sought to provide a roadmap for managing the irAEs and complications of cell-based therapies, with an emphasis on early detection, gradation, and tailored, often multidisciplinary, therapeutic strategies. Patient education and the constant evolution of our knowledge are key to securing these advances. By mastering these aspects, we will be able to fully exploit the potential of these hopeful treatments, significantly improving the outcome and quality of life of our patients.…mehr

Andere Kunden interessierten sich auch für
Produktbeschreibung
Immunotherapies have transformed the landscape of cancer treatment, but their power comes with specific toxic challenges. This book has sought to provide a roadmap for managing the irAEs and complications of cell-based therapies, with an emphasis on early detection, gradation, and tailored, often multidisciplinary, therapeutic strategies. Patient education and the constant evolution of our knowledge are key to securing these advances. By mastering these aspects, we will be able to fully exploit the potential of these hopeful treatments, significantly improving the outcome and quality of life of our patients.
Autorenporträt
Onkolog specjalizuj¿cy si¿ w leczeniu raka piersi, dr Bentouati Abdelkader jest równie¿ starszym wyk¿adowc¿ z ponad dwudziestoletnim döwiadczeniem klinicznym i akademickim w tej dziedzinie.